Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Authors : Lopes Renato D RD; Alexander John H JH; Al-Khatib Sana M SM; Ansell Jack J; Diaz Raphael R; Easton J Donald JD; Gersh Bernard J BJ; Granger Christopher B CB; Hanna Michael M; Horowitz John J; Hylek Elaine M EM; McMurray John J V JJ; Verheugt Freek W A FW; Wallentin Lars L; ;
Affiliations : Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Journal : Am. Heart J. (2010)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...